Eléments de l'association
|
List of bibliographic references
Number of relevant bibliographic references: 7.Ident. | Authors (with country if any) | Title |
---|---|---|
000E94 | T. Debeir [France] ; M. Marien [France] ; P. Chopin [France] ; J.-C. Martel [France] ; F. Colpaert [France] ; R. Raisman-Vozari [France] | Protective effects of the α2-adrenoceptor antagonist, dexefaroxan, against degeneration of the basalocortical cholinergic system induced by cortical devascularization in the adult rat |
001302 | M. Vila [France] ; C. Marin [Espagne] ; M. Ruberg [France] ; A. Jimenez [Espagne] ; R. Raisman-Vozari [France] ; Yves Agid [France] ; E. Tolosa [Espagne] ; E. C. Hirsch [France] | Systemic administration of NMDA and AMPA receptor antagonists reverses the neurochemical changes induced by nigrostriatal denervation in basal ganglia |
001326 | M. G. Murer [Argentine] ; R. Raisman-Vozari [France] ; O. Gershanik [Argentine] | Levodopa in Parkinson's disease : Neurotoxicity issue laid to rest? |
001463 | M. G. Murer [France] ; G. Dziewczapolski [Argentine] ; L. B. Menalled [Argentine] ; M. C. Garcia [Argentine] ; Yves Agid [France] ; O. Gershanik [Argentine] ; R. Raisman-Vozari [France] | Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions |
001599 | G. Dziewczapolski [Argentine] ; G. Murer [France] ; Yves Agid [France] ; O. S. Gershanik [Argentine] ; R. Raisman-Vozari [France] | Absence of neurotoxicity of chronic L-DOPA in 6-hydroxydopamine-lesioned rats |
001722 | V. Blanchard [France] ; M. Chritin ; SHEELA VYAS [France] ; M. Savasta ; C. Feuerstein ; Yves Agid [France] ; F. Javoy-Agid [France] ; R. Raisman-Vozari [France] | Long-term induction of tyrosine hydroxylase expression : compensatory response to partial degeneration of the dopaminergic nigrostriatal system in the rat brain |
001A54 | R. Raisman-Vozari ; J.-A. Girault ; S. Moussaoui ; C. Feuerstein ; P. Jenner ; C. D. Marsden ; Yves Agid [France] | Lack of change in triatal DARPP-32 levels following nigrostriatal dopaminergic lesions in animals and in parkinsonian syndromes in man |
This area was generated with Dilib version V0.6.29. |